Sponsors / TLSA
TLSA

Tiziana Life Sciences LTD

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
3Trials in this database
2Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsNCT06292923TLSAPhase 2Active not recruiting2026-09Estimated
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)NCT06868628TLSAPhase 2Recruiting2027-04-01Estimated
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisNCT06890923TLSAPhase 2Recruiting2026-04-30Estimated

Latest recorded trial changes